Statements (59)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:patches
|
| gptkbp:age_group |
18 years and older
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:clinical_trial |
Phase 3
skin hydration nasolabial folds fine lines facial rejuvenation wrinkles skin texture improvement cheek augmentation chin augmentation crow's feet facial contouring facial volume loss marionette lines forehead wrinkles lip definition lip lines lip volume enhancement non-surgical rhinoplasty overall facial balance perioral lines skin elasticity improvement smile lines tear trough correction temporal volume loss |
| gptkbp:clinical_use |
cosmetic procedures
aesthetic medicine |
| gptkbp:contains |
hyaluronic acid
|
| gptkbp:contraindication |
active skin infection
allergy to hyaluronic acid |
| gptkbp:cross_linking_technology |
Vycross
|
| gptkbp:duration |
up to 1 year
|
| gptkbp:duration_of_procedure |
30 minutes
|
| gptkbp:events |
recommended
|
| gptkbp:formulation |
gptkb:gel
|
| https://www.w3.org/2000/01/rdf-schema#label |
Juvederm Ultra XC
|
| gptkbp:marketed_as |
gptkb:Canada
gptkb:European_Union gptkb:United_States |
| gptkbp:packaging |
syringe
|
| gptkbp:patient_satisfaction_rate |
high
|
| gptkbp:produced_by |
gptkb:Allergan
|
| gptkbp:route_of_administration |
injection
|
| gptkbp:side_effect |
bruising
swelling redness pain at injection site |
| gptkbp:specialties |
ice application
avoidance of alcohol avoidance of strenuous exercise |
| gptkbp:storage |
room temperature
|
| gptkbp:used_for |
lip augmentation
|
| gptkbp:website |
linear threading
serial puncture |
| gptkbp:weight |
high
|
| gptkbp:bfsParent |
gptkb:Juvederm
|
| gptkbp:bfsLayer |
6
|